Despite declining fertility in their midlife, many
Blog
-
Safe Contraceptive Options for Perimenopausal Women in 2025
women remain at risk for unintended pregnancy during perimenopause—a stage whencardiovascular risk , metabolic disease, and pregnancy-related complications rise sharply. Yet, contraceptive… -
Celebrity Cruises Takes Delivery of Celebrity Xcel, Announces Celebrity Xcite – Cruise Critic
- Celebrity Cruises Takes Delivery of Celebrity Xcel, Announces Celebrity Xcite Cruise Critic
- Royal Caribbean Group hits 3 major cruise milestones, and it proves its chairman’s important lesson Royal Caribbean Blog
- Celebrity Cruises Ushers in a New…
Continue Reading
-
CHEST 2025: Advancing Respiratory Virus Vaccines and Improving Uptake Among High-Risk Populations
Although employed by the US Department of Veterans Affairs (VA), Crothers is not representing the VA, and the views expressed are her own.
Pharmacy Times: What are the most significant recent advancements in vaccines for respiratory viruses like…
Continue Reading
-
Just a moment…
Just a moment… This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Continue Reading
-
Researchers link gum disease to increased risk of stroke, brain damage
If you need another reason to brush and floss, here it is: Research suggests keeping your mouth healthy might also protect your brain and heart.
Two new studies published Wednesday in Neurology Open Access linked gum disease and cavities to a…
Continue Reading
-
New Study Reveals East African Media’s Blind Spot in Femicide and SGBV Reporting – The Aga Khan University
- New Study Reveals East African Media’s Blind Spot in Femicide and SGBV Reporting The Aga Khan University
- Study reveals East African media’s SGBV coverage gaps A new study by the Aga Khan University’s Graduate School of Media and…
Continue Reading
-
High order intake: HENSOLDT raises guidance for book-to-bill ratio and specifies outlook for revenue and adjusted EBITDA margin
Sensor specialist HENSOLDT is adjusting its guidance for the 2025 financial year following recent and further foreseeable order intake. The company now expects a significantly increased book-to-bill ratio of 1.6x to 1.9x, whereas previous expectations were approximately 1.2x. In addition, the expected revenue is specified at approximately 2,500 million euro (previously: range of 2,500–2,600 million Euro) and the adjusted EBITDA margin at 18% or higher (previously: approximately 18%). At the same time, the company confirms its medium-term guidance and revenue ambition for 2030.
Following the German government’s decision to initiate further procurement in numerous defence programmes due to the continuing high threat level, this is now increasingly reflected in concrete orders. With its solutions meeting current and future security requirements, HENSOLDT is benefiting considerably from this. As a result, the recent orders will push the book-to-bill ratio for 2025 above the previously expected 1.2x.
The increasing order intake also comes with a clear mandate: industrial scaling of its programmes remains a top priority for HENSOLDT. The company is expanding its capacities through automation measures, a new logistics centre and a new building in Oberkochen. In addition, comprehensive transformation initiatives in the areas of operations, engineering and supply chain are driving efficiency, flexibility and resilience. Despite the high complexity of the ramp-up, HENSOLDT is well on track here. At the same time, profitability remains secure: the specification in the EBITDA margin clearly shows that HENSOLDT is capable of efficiently execute the increased orders and operate successfully in economic terms.
Oliver Dörre, CEO of HENSOLDT, explains: “The fact that Germany is investing strongly in its own security due to the current security situation and that this political will is now being reflected in concrete orders is an important step towards genuine defence capability. Thanks to innovative technologies and the consistent expansion of our industrial capacity, we are well positioned to make an important contribution to this. This demonstrates HENSOLDT’s ability to reliably deliver complex products and solutions even in the face of significantly increasing demand.”
Christian Ladurner, CFO of HENSOLDT, says: “The raise of our book-to-bill ratio and the specification of the adjusted EBITDA margin shows that HENSOLDT is not only growing but also continuing to operate profitably. Through targeted investments in capacity and processes, we are securing our delivery capability and sustainable growth. At the same time, our company’s operational strength forms the basis for consistently implementing our strategic priorities.”
Continue Reading
-
Wyoming dinosaur 'mummies' reveal a surprise: hoofed feet – Reuters
- Wyoming dinosaur ‘mummies’ reveal a surprise: hoofed feet Reuters
- 100-year-old mystery of Wyoming’s duck-billed dinosaur ‘mummies’ finally solved BBC Wildlife Magazine
- Two New Dinosaur Fossils Emerge From the ‘Mummy Zone’ The New York…
Continue Reading
-
Revolutionizing cataract surgery with office-based oral sedation
A new study on office-based cataract surgery is challenging traditional approaches to the procedure, demonstrating that patients can undergo successful surgery with minimal oral sedation instead of with intravenous (IV) sedation at…
Continue Reading
-
Cellarity Publishes Framework for Discovery of Cell State-Correcting Medicines in Science
SOMERVILLE, Mass.–(BUSINESS WIRE)–Cellarity, a biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the publication of a seminal manuscript in the journal Science,…
Continue Reading